Jasper Therapeutics, Inc. (JSPR) News
Track canonical SquawkNews coverage tagged to JSPR, Jasper Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
JSPR - Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
JSPR - Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
NEWS | Sep 15, 2026, 08:05 PM UTC
L
Jasper Therapeutics to present at H.C. Wainwright global investment conference
Jasper Therapeutics said management will participate at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 09, 2026, 12:01 PM UTC
L
JSPR - Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
JSPR - Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 09, 2026, 12:00 PM UTC
L
Jasper Therapeutics reports Q2 2026 results and corporate update
Jasper Therapeutics (JSPR) reports its second quarter 2026 financial results and provides a corporate update, according to TradeXchange Newsdesk.
EARNINGS | Aug 14, 2026, 03:00 PM UTC
M
Piper Initiates JSPR, LPTH, MRCY, UMAC Overweight
Piper initiates JSPR, LPTH, MRCY, UMAC at overweight, while JPM starts FLUT at neutral and Chardan starts QMLS at buy
EQUITY | Aug 12, 2026, 10:47 AM UTC
M
JSPR Initiated Overweight at Piper
JSPR initiated with Overweight rating at Piper with $2 price target
EQUITY | Aug 12, 2026, 09:44 AM UTC
H
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives
New On The Block Lulu’s Fashion Lounge Holdings (NASDAQ: LVLU ) retained Solomon Partners as its financial advisor and Willkie Farr & Gallagher LLP as its legal advisor as the company evaluates strategic alternatives to
EARNINGS | Jul 17, 2026, 05:18 PM UTC
H
Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Shares of Callan JMB Inc (NASDAQ: CJMB ) rose sharply in pre-market trading following the announcement that Callan JMB signed a strategic partnership with Alabama State University to build an integrated pharmaceutical ma
MACRO | Jul 17, 2026, 08:48 AM UTC
L
JSPR - resumes trading after halt, +59% in AHs
JSPR - resumes trading after halt, +59% in AHs
EQUITY | Jul 16, 2026, 09:48 PM UTC
H
JSPR - PR: Jasper Therapeutics Announces Merger with Kira Pharmaceuticals -Combined company positioned to advance portfolio of biologic agen
JSPR - PR: Jasper Therapeutics Announces Merger with Kira Pharmaceuticals -Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven
MNA | Jul 16, 2026, 09:20 PM UTC